Prospera Financial Services Inc Bristol Myers Squibb CO Transaction History

Prospera Financial Services Inc

  • $4.16 Billion
  • Q4 2024

A detailed history of Prospera Financial Services Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Prospera Financial Services Inc holds 50,900 shares of BMY stock, worth $2.99 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
50,900
Previous 73,255 30.52%
Holding current value
$2.99 Million
Previous $3.79 Million 24.06%
% of portfolio
0.07%
Previous 0.1%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$51.92 - $59.94 $1.16 Million - $1.34 Million
-22,355 Reduced 30.52%
50,900 $2.88 Million
Q3 2024

Nov 07, 2024
BUY
$39.66 - $51.75 $829,528 - $1.08 Million
20,916 Added 39.96%
73,255 $3.79 Million
Q2 2024

Aug 13, 2024
BUY
$40.25 - $52.99 $973,043 - $1.28 Million
24,175 Added 85.84%
52,339 $2.17 Million
Q1 2024

Aug 13, 2024
SELL
$47.98 - $54.4 $560,982 - $636,044
-11,692 Reduced 22.34%
40,647 $2.2 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $160,905 - $192,004
-3,319 Reduced 10.54%
28,164 $1.45 Million
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $237,349 - $265,393
4,100 Added 14.97%
31,483 $1.83 Million
Q2 2023

Aug 08, 2023
BUY
$63.71 - $70.74 $46,572 - $51,710
731 Added 2.74%
27,383 $1.75 Million
Q1 2023

May 12, 2023
SELL
$65.71 - $74.53 $10,710 - $12,148
-163 Reduced 0.61%
26,652 $1.85 Million
Q4 2022

Feb 08, 2023
SELL
$68.48 - $81.09 $31,500 - $37,301
-460 Reduced 1.69%
26,815 $1.93 Million
Q3 2022

Oct 27, 2022
BUY
$0.13 - $76.84 $149 - $88,135
1,147 Added 4.39%
27,275 $1.94 Million
Q2 2022

Aug 08, 2022
BUY
$72.62 - $79.98 $235,724 - $259,615
3,246 Added 14.19%
26,128 $2.01 Million
Q1 2022

May 04, 2022
BUY
$61.48 - $73.72 $22,255 - $26,686
362 Added 1.61%
22,882 $1.67 Million
Q4 2021

Feb 10, 2022
BUY
$53.63 - $62.52 $316,577 - $369,055
5,903 Added 35.52%
22,520 $1.41 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $417,030 - $488,496
-7,048 Reduced 29.78%
16,617 $984,000
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $296,177 - $322,537
4,784 Added 25.34%
23,665 $1.58 Million
Q1 2021

May 06, 2021
SELL
$59.34 - $66.74 $154,105 - $173,323
-2,597 Reduced 12.09%
18,881 $1.19 Million
Q4 2020

Feb 12, 2021
BUY
$57.74 - $65.43 $501,471 - $568,259
8,685 Added 67.89%
21,478 $1.33 Million
Q3 2020

Nov 04, 2020
SELL
$57.43 - $63.64 $172,979 - $191,683
-3,012 Reduced 19.06%
12,793 $771,000
Q2 2020

Aug 07, 2020
BUY
$54.82 - $64.09 $20,667 - $24,161
377 Added 2.44%
15,805 $929,000
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $286,288 - $416,043
-6,170 Reduced 28.57%
15,428 $860,000
Q4 2019

Feb 12, 2020
BUY
$49.21 - $64.19 $492,493 - $642,413
10,008 Added 86.35%
21,598 $1.39 Million
Q3 2019

Oct 22, 2019
BUY
$42.77 - $50.71 $30,708 - $36,409
718 Added 6.6%
11,590 $588,000
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $1.79 Million - $1.98 Million
40,057 New
40,057 $2.06 Million
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $1.3 Million - $1.44 Million
-29,185 Reduced 72.86%
10,872 $495,000
Q1 2019

May 02, 2019
SELL
$45.12 - $53.8 $1.81 Million - $2.16 Million
-40,057 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$48.76 - $63.23 $134,138 - $173,945
-2,751 Reduced 6.43%
40,057 $2.06 Million
Q3 2018

Oct 25, 2018
SELL
$55.19 - $62.25 $348,855 - $393,482
-6,321 Reduced 12.87%
42,808 $2.58 Million
Q2 2018

Jul 18, 2018
SELL
$50.53 - $62.98 $1,768 - $2,204
-35 Reduced 0.07%
49,129 $2.73 Million
Q1 2018

Apr 12, 2018
SELL
$59.92 - $68.98 $131,584 - $151,480
-2,196 Reduced 4.28%
49,164 $3.1 Million
Q4 2017

Jan 24, 2018
SELL
$59.94 - $65.35 $777,182 - $847,328
-12,966 Reduced 20.16%
51,360 $3.16 Million
Q3 2017

Oct 11, 2017
BUY
$55.23 - $63.74 $3.55 Million - $4.1 Million
64,326
64,326 $4.14 Million

Others Institutions Holding BMY

# of Institutions
2,754
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email